Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

CSL reported $36.23B in Assets for its fiscal semester ending in June of 2023.

Assets Change Date
Aceragen USD 78.49M 22.62M Mar/2023
Acorda Therapeutics USD 364.7M 10.21M Jun/2023
Adamis Pharmaceuticals USD 9.08M 1.85M Mar/2023
Agile Therapeutics USD 10.89M 1.68M Sep/2023
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
Bio Path USD 5.02M 1.5M Sep/2023
Brainstorm Cell Therapeutics USD 5.68M 65K Sep/2023
Cara Therapeutics USD 115.34M 19.05M Sep/2023
CSL USD 36.23B 786.4M Jun/2023
Curis USD 89.98M 5.67M Sep/2023
Esperion Therapeutics USD 221.3M 13.32M Sep/2023
Immunic USD 66.98M 21.76M Sep/2023
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
Life Technologies USD 125.07M 7.68M Sep/2023
Lumos Pharma USD 47.75M 8.62M Sep/2023
Minerva Neurosciences USD 63.13M 4.01M Sep/2023
Regulus Therapeutics USD 37.75M 5.9M Sep/2023
TherapeuticsMD USD 50.49M 3.2M Sep/2023